Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Invivyd (NASDAQ:IVVD) through any online brokerage.
Other companies in Invivyd’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Invivyd has a consensus price target of $7.57.
The stock price for Invivyd (NASDAQ: IVVD) is $0.7417 last updated October 7, 2026 at 6:39 PM EDT.
There are no upcoming dividends for Invivyd.
Invivyd does not have any upcoming earnings scheduled.
There is no upcoming split for Invivyd.
Invivyd is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.